<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 25 Mar 2021 17:15:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</guid>
   <pubDate>Thu, 25 Mar 2021 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</guid>
   <pubDate>Thu, 25 Mar 2021 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</guid>
   <pubDate>Thu, 25 Mar 2021 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</guid>
   <pubDate>Thu, 25 Mar 2021 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</guid>
   <pubDate>Thu, 25 Mar 2021 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Reports+2020+Year+End+Financial+Results+and+Provides+Business+Update/18178093.html</guid>
   <pubDate>Thu, 25 Mar 2021 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html</guid>
   <pubDate>Thu, 11 Mar 2021 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html</guid>
   <pubDate>Thu, 11 Mar 2021 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual Meeting</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html</guid>
   <pubDate>Thu, 11 Mar 2021 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual Meeting</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+To+Present+New+Data+on+PD-1+Targeting+INTASYL+at+the+2021+American+Association+for+Cancer+Research+%28AACR%29+Annual+Meeting/18112744.html</guid>
   <pubDate>Thu, 11 Mar 2021 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</guid>
   <pubDate>Mon, 01 Mar 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</guid>
   <pubDate>Mon, 01 Mar 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</guid>
   <pubDate>Mon, 01 Mar 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</guid>
   <pubDate>Mon, 01 Mar 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</guid>
   <pubDate>Mon, 01 Mar 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+and+AgonOx%2C+Inc.+Announce+Collaboration+on+Clinical+Development+of+Novel+T+Cell-based+Cancer+Immunotherapies/18052742.html</guid>
   <pubDate>Mon, 01 Mar 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.34356544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Corp. (PHIO) Announces $7.7 Million Registered Direct Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html</guid>
   <pubDate>Fri, 12 Feb 2021 07:06:50 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Corp. (PHIO) Announces $7.7 Million Registered Direct Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html</guid>
   <pubDate>Fri, 12 Feb 2021 07:06:50 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Corp. (PHIO) Announces $7.7 Million Registered Direct Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Corporate+News/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html</guid>
   <pubDate>Fri, 12 Feb 2021 07:06:50 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Corp. (PHIO) Announces $7.7 Million Registered Direct Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Corporate+News/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Phio+Pharmaceuticals+Corp.+%28PHIO%29+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock/17961721.html</guid>
   <pubDate>Fri, 12 Feb 2021 07:06:50 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html</guid>
   <pubDate>Fri, 12 Feb 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html</guid>
   <pubDate>Fri, 12 Feb 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html</guid>
   <pubDate>Fri, 12 Feb 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market</title>
   <link>http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Phio+Pharmaceuticals+Announces+%247.7+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-the-Market/17961664.html</guid>
   <pubDate>Fri, 12 Feb 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
  <item>
   <title>Phio Pharmaceuticals Announces Closing of $14.0 Million Private Placement Priced At-the-Market</title>
   <link>http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+Closing+of+%2414.0+Million+Private+Placement+Priced+At-the-Market/17859872.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+Closing+of+%2414.0+Million+Private+Placement+Priced+At-the-Market/17859872.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Phio+Pharmaceuticals+Announces+Closing+of+%2414.0+Million+Private+Placement+Priced+At-the-Market/17859872.html</guid>
   <pubDate>Mon, 25 Jan 2021 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PHIO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RXII</category>
   	  </item>
 </channel>
</rss>
